HCA Healthcare (HCA) Q3 2025 Financial Results Summary

By
QuoteReporter
-
0
4

HCA Healthcare (HCA) Q3 2025 Financial Results Summary

Nashville, Tenn., October 24, 2025 – HCA Healthcare, Inc. (NYSE: HCA) announced its financial and operating results for the third quarter ended September 30, 2025. Below is a summary of the key financial metrics and operational performance compared to the same quarter in 2024, highlighting significant changes:

Financial Summary

  • Revenues:

  • Increased by 9.6% to $19.161 billion from $17.487 billion in Q3 2024.

  • Net Income Attributable to HCA:

  • Rose by 29.4% to $1.643 billion from $1.270 billion YoY.

  • Diluted Earnings Per Share:

  • Improved by 42.6% to $6.96 compared to $4.88 in the previous year.

  • Adjusted diluted earnings per share also increased to $6.96.

  • Adjusted EBITDA:

  • Increased by 18.5% to $3.870 billion from $3.267 billion in Q3 2024.

  • Cash Flows from Operating Activities:

  • Totaled $4.416 billion, an increase from $3.515 billion in Q3 2024.

Operational Metrics

  • Same Facility Admissions:

  • Increased by 2.1% in Q3 2025, totaling 567,382 admissions compared to 555,707 in Q3 2024.

  • Same Facility Equivalent Admissions:

  • Increased by 2.4% to 1,008,805 from 985,269 in the previous year.

  • Same Facility Emergency Room Visits:

  • Increased by 1.3% to 2,439,405 visits from 2,408,379 YoY.

  • Same Facility Inpatient Surgeries:

  • Saw an increase of 1.4% to 136,467 from 134,623 a year prior.

  • Same Facility Outpatient Surgeries:

  • Increased by 1.1% to 248,367 from 245,600 in the prior year.

  • Same Facility Revenue per Equivalent Admission:

  • Rose by 6.6% to $18,390 compared to $17,245 in Q3 2024.

Nine-Month Performance Summary (YTD)

  • Revenues for Nine Months:

  • Increased by 7.0% to $56.087 billion from $52.318 billion in the first nine months of 2024.

  • Net Income Attributable to HCA (YTD):

  • Increased to $4.906 billion, up 13.5% from $4.322 billion.

  • Diluted Earnings Per Share (YTD):

  • Increased to $20.23, up 23.5% from $16.37 in 2024.

Balance Sheet Highlights

  • Cash and Cash Equivalents:

  • Reported at $997 million, compared to $1.933 billion at the end of Q3 2024.

  • Total Debt:

  • Stood at $44.511 billion.

  • Total Assets:

  • Reported at $59.747 billion.

Dividends and Share Repurchase

  • HCA Healthcare declared a quarterly cash dividend of $0.72 per share.
  • The dividend will be paid on December 29, 2025, to stockholders of record on December 15, 2025.
  • During the third quarter, HCA repurchased 6.514 million shares of its common stock at a cost of $2.498 billion.

2025 Guidance Update

  • Revised Revenue Guidance: Increased to a range of $75.000 to $76.500 billion from the previous $74.000 to $76.000 billion.

  • Net Income Guidance: Updated to $6.495 to $6.715 billion.

  • Adjusted EBITDA Guidance: Revised to $15.250 to $15.650 billion.

  • EPS Guidance: Adjusted to a range of $27.00 to $28.00 per diluted share.

Conclusion

HCA Healthcare’s third-quarter results reflect solid growth in both revenue and profitability metrics, along with strategic share repurchase and a dividend declaration, signaling continued strength and operational efficiency within the organization. All metrics show a positive trajectory compared to the same quarter last year.

Here are the extracted tables from the press release:

HCA Healthcare, Inc. Condensed Consolidated Comprehensive Income Statements Third Quarter Unaudited (Dollars in millions, except per share amounts)

2025 Ratio 2024 Ratio
Revenues $19,161 100.0 % $17,487 100.0 %
Salaries and benefits 8,364 43.6 7,861 45.0
Supplies 2,782 14.5 2,657 15.2
Other operating expenses 4,161 21.8 3,717 21.2
Equity in earnings of affiliates (16) (0.1) (15) (0.1)
Depreciation and amortization 889 4.7 842 4.9
Interest expense 561 2.9 515 2.9
Losses on sales of facilities 2 — 4 —
16,743 87.4 15,581 89.1
Income before income taxes 2,418 12.6 1,906 10.9
Provision for income taxes 515 2.7 424 2.4
Net income 1,903 9.9 1,482 8.5
Net income attributable to 260 1.3 212 1.2
noncontrolling interests
Net income attributable to HCA $1,643 8.6 $1,270 7.3
Healthcare, Inc.
Diluted earnings per share $6.96 $4.88
Shares used in computing diluted 236.181 259.917
earnings per share (millions)
Comprehensive income attributable to HCA $1,635 $1,325
Healthcare, Inc.

HCA Healthcare, Inc. Condensed Consolidated Balance Sheets Unaudited (Dollars in millions)

ASSETS September 30, 2025 June 30, 2025 December 31, 2024
Current assets:
Cash and cash equivalents $997 $939 $1,933
Accounts receivable 10,428 10,459 10,751
Inventories 1,734 1,792 1,738
Other 2,126 2,373 1,992
15,285 15,563 16,414
Property and equipment, at cost 65,489 64,388 62,514
Accumulated depreciation (34,921) (34,265) (33,100)
30,568 30,123 29,414
Investments of insurance subsidiaries 573 531 569
Investments in and advances to affiliates 654 654 662
Goodwill and other intangible assets 10,275 10,273 10,093
Right-of-use operating lease assets 2,115 2,156 2,131
Other 277 236 230
$59,747 $59,536 $59,513
LIABILITIES AND STOCKHOLDERS’ (DEFICIT)
EQUITY
Current liabilities:
Accounts payable $4,552 $4,250 $4,276
Accrued salaries 2,294 2,072 2,304
Other accrued expenses 4,940 4,513 3,899
Short-term borrowings and long-term debt due within one year 6,110 5,104 4,698
17,896 15,939 15,177
Long-term debt, less debt issuance costs and discounts 38,401 39,379 38,333
Professional liability risks 1,462 1,506 1,544
Right-of-use operating lease obligations 1,838 1,881 1,863
Income taxes and other liabilities 2,309 2,069 2,041
Stockholders’ (deficit) equity:
Stockholders’ deficit attributable to (5,335) (4,394) (2,499)
HCA Healthcare, Inc.
Noncontrolling interests 3,176 3,156 3,054
(2,159) (1,238) 555
$59,747 $59,536 $59,513

RELATED ARTICLESMORE FROM AUTHOR